脳腫瘍の治療世界市場の発展状況と動向 2024-2030
英文タイトル: Global Brain Tumor Treatment Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は脳腫瘍の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは脳腫瘍の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界の脳腫瘍の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは脳腫瘍の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に脳腫瘍の治療市場を分類しています。本研究に含まれる主な企業は:Genetech (U.S.)、Bristol Mayers Squibb (U.S.)、Hoffman-La Roche (Switzerland)、Astra Zeneca (India)、Pfizer (U.S.)、Novartis (Switzerland)、Antisenese Pharma (Mongolia)、Merck (U.S.)、Mcleod’s Pharmaceuticals (India)、Mankind Pharma (India)、Dr. Reddy’s Laboratories (India)
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Chemotherapy
Targeted Therapy
用途別の市場セグメント:
Early
Mid-term
Later period
本レポートの詳細内容
世界の脳腫瘍の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、脳腫瘍の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の脳腫瘍の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の脳腫瘍の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、脳腫瘍の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
脳腫瘍の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:脳腫瘍の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:脳腫瘍の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章脳腫瘍の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:脳腫瘍の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:脳腫瘍の治療の主要企業の概要を提供し、製品の説明と仕様、脳腫瘍の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health. Market Analysis and Insights: Global Brain Tumor Treatment Market The global Brain Tumor Treatment market is projected to grow from US$ 2181.3 million in 2024 to US$ 3539 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Report Covers: This report presents an overview of global market for Brain Tumor Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Brain Tumor Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Brain Tumor Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Brain Tumor Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Brain Tumor Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Brain Tumor Treatment revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Genetech (U.S.), Bristol Mayers Squibb (U.S.), Hoffman-La Roche (Switzerland), Astra Zeneca (India), Pfizer (U.S.), Novartis (Switzerland), Antisenese Pharma (Mongolia), Merck (U.S.) and Mcleod’s Pharmaceuticals (India), etc. Market Segmentation By Company Genetech (U.S.) Bristol Mayers Squibb (U.S.) Hoffman-La Roche (Switzerland) Astra Zeneca (India) Pfizer (U.S.) Novartis (Switzerland) Antisenese Pharma (Mongolia) Merck (U.S.) Mcleod’s Pharmaceuticals (India) Mankind Pharma (India) Dr. Reddy’s Laboratories (India) Segment by Type Chemotherapy Targeted Therapy Segment by Application Early Mid-term Later period By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Brain Tumor Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Brain Tumor Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain Tumor Treatment revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Tumor Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.3 Market by Application
1.3.1 Global Brain Tumor Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Early
1.3.3 Mid-term
1.3.4 Later period
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Treatment Market Perspective (2019-2030)
2.2 Global Brain Tumor Treatment Growth Trends by Region
2.2.1 Brain Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Tumor Treatment Historic Market Size by Region (2019-2024)
2.2.3 Brain Tumor Treatment Forecasted Market Size by Region (2025-2030)
2.3 Brain Tumor Treatment Market Dynamics
2.3.1 Brain Tumor Treatment Industry Trends
2.3.2 Brain Tumor Treatment Market Drivers
2.3.3 Brain Tumor Treatment Market Challenges
2.3.4 Brain Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Brain Tumor Treatment by Players
3.1.1 Global Brain Tumor Treatment Revenue by Players (2019-2024)
3.1.2 Global Brain Tumor Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Brain Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Brain Tumor Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Brain Tumor Treatment Market Concentration Ratio
3.4.1 Global Brain Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Treatment Revenue in 2023
3.5 Global Key Players of Brain Tumor Treatment Head office and Area Served
3.6 Global Key Players of Brain Tumor Treatment, Product and Application
3.7 Global Key Players of Brain Tumor Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Tumor Treatment Breakdown Data by Type
4.1 Global Brain Tumor Treatment Historic Market Size by Type (2019-2024)
4.2 Global Brain Tumor Treatment Forecasted Market Size by Type (2025-2030)
5 Brain Tumor Treatment Breakdown Data by Application
5.1 Global Brain Tumor Treatment Historic Market Size by Application (2019-2024)
5.2 Global Brain Tumor Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Tumor Treatment Market Size (2019-2030)
6.2 North America Brain Tumor Treatment Market Size by Type
6.2.1 North America Brain Tumor Treatment Market Size by Type (2019-2024)
6.2.2 North America Brain Tumor Treatment Market Size by Type (2025-2030)
6.2.3 North America Brain Tumor Treatment Market Share by Type (2019-2030)
6.3 North America Brain Tumor Treatment Market Size by Application
6.3.1 North America Brain Tumor Treatment Market Size by Application (2019-2024)
6.3.2 North America Brain Tumor Treatment Market Size by Application (2025-2030)
6.3.3 North America Brain Tumor Treatment Market Share by Application (2019-2030)
6.4 North America Brain Tumor Treatment Market Size by Country
6.4.1 North America Brain Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Brain Tumor Treatment Market Size by Country (2019-2024)
6.4.3 North America Brain Tumor Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Brain Tumor Treatment Market Size (2019-2030)
7.2 Europe Brain Tumor Treatment Market Size by Type
7.2.1 Europe Brain Tumor Treatment Market Size by Type (2019-2024)
7.2.2 Europe Brain Tumor Treatment Market Size by Type (2025-2030)
7.2.3 Europe Brain Tumor Treatment Market Share by Type (2019-2030)
7.3 Europe Brain Tumor Treatment Market Size by Application
7.3.1 Europe Brain Tumor Treatment Market Size by Application (2019-2024)
7.3.2 Europe Brain Tumor Treatment Market Size by Application (2025-2030)
7.3.3 Europe Brain Tumor Treatment Market Share by Application (2019-2030)
7.4 Europe Brain Tumor Treatment Market Size by Country
7.4.1 Europe Brain Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Brain Tumor Treatment Market Size by Country (2019-2024)
7.4.3 Europe Brain Tumor Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Brain Tumor Treatment Market Size (2019-2030)
8.2 China Brain Tumor Treatment Market Size by Type
8.2.1 China Brain Tumor Treatment Market Size by Type (2019-2024)
8.2.2 China Brain Tumor Treatment Market Size by Type (2025-2030)
8.2.3 China Brain Tumor Treatment Market Share by Type (2019-2030)
8.3 China Brain Tumor Treatment Market Size by Application
8.3.1 China Brain Tumor Treatment Market Size by Application (2019-2024)
8.3.2 China Brain Tumor Treatment Market Size by Application (2025-2030)
8.3.3 China Brain Tumor Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Brain Tumor Treatment Market Size (2019-2030)
9.2 Asia Brain Tumor Treatment Market Size by Type
9.2.1 Asia Brain Tumor Treatment Market Size by Type (2019-2024)
9.2.2 Asia Brain Tumor Treatment Market Size by Type (2025-2030)
9.2.3 Asia Brain Tumor Treatment Market Share by Type (2019-2030)
9.3 Asia Brain Tumor Treatment Market Size by Application
9.3.1 Asia Brain Tumor Treatment Market Size by Application (2019-2024)
9.3.2 Asia Brain Tumor Treatment Market Size by Application (2025-2030)
9.3.3 Asia Brain Tumor Treatment Market Share by Application (2019-2030)
9.4 Asia Brain Tumor Treatment Market Size by Region
9.4.1 Asia Brain Tumor Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Brain Tumor Treatment Market Size by Region (2019-2024)
9.4.3 Asia Brain Tumor Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Brain Tumor Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Brain Tumor Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Genetech (U.S.)
11.1.1 Genetech (U.S.) Company Details
11.1.2 Genetech (U.S.) Business Overview
11.1.3 Genetech (U.S.) Brain Tumor Treatment Introduction
11.1.4 Genetech (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024)
11.1.5 Genetech (U.S.) Recent Developments
11.2 Bristol Mayers Squibb (U.S.)
11.2.1 Bristol Mayers Squibb (U.S.) Company Details
11.2.2 Bristol Mayers Squibb (U.S.) Business Overview
11.2.3 Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Introduction
11.2.4 Bristol Mayers Squibb (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024)
11.2.5 Bristol Mayers Squibb (U.S.) Recent Developments
11.3 Hoffman-La Roche (Switzerland)
11.3.1 Hoffman-La Roche (Switzerland) Company Details
11.3.2 Hoffman-La Roche (Switzerland) Business Overview
11.3.3 Hoffman-La Roche (Switzerland) Brain Tumor Treatment Introduction
11.3.4 Hoffman-La Roche (Switzerland) Revenue in Brain Tumor Treatment Business (2019-2024)
11.3.5 Hoffman-La Roche (Switzerland) Recent Developments
11.4 Astra Zeneca (India)
11.4.1 Astra Zeneca (India) Company Details
11.4.2 Astra Zeneca (India) Business Overview
11.4.3 Astra Zeneca (India) Brain Tumor Treatment Introduction
11.4.4 Astra Zeneca (India) Revenue in Brain Tumor Treatment Business (2019-2024)
11.4.5 Astra Zeneca (India) Recent Developments
11.5 Pfizer (U.S.)
11.5.1 Pfizer (U.S.) Company Details
11.5.2 Pfizer (U.S.) Business Overview
11.5.3 Pfizer (U.S.) Brain Tumor Treatment Introduction
11.5.4 Pfizer (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024)
11.5.5 Pfizer (U.S.) Recent Developments
11.6 Novartis (Switzerland)
11.6.1 Novartis (Switzerland) Company Details
11.6.2 Novartis (Switzerland) Business Overview
11.6.3 Novartis (Switzerland) Brain Tumor Treatment Introduction
11.6.4 Novartis (Switzerland) Revenue in Brain Tumor Treatment Business (2019-2024)
11.6.5 Novartis (Switzerland) Recent Developments
11.7 Antisenese Pharma (Mongolia)
11.7.1 Antisenese Pharma (Mongolia) Company Details
11.7.2 Antisenese Pharma (Mongolia) Business Overview
11.7.3 Antisenese Pharma (Mongolia) Brain Tumor Treatment Introduction
11.7.4 Antisenese Pharma (Mongolia) Revenue in Brain Tumor Treatment Business (2019-2024)
11.7.5 Antisenese Pharma (Mongolia) Recent Developments
11.8 Merck (U.S.)
11.8.1 Merck (U.S.) Company Details
11.8.2 Merck (U.S.) Business Overview
11.8.3 Merck (U.S.) Brain Tumor Treatment Introduction
11.8.4 Merck (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024)
11.8.5 Merck (U.S.) Recent Developments
11.9 Mcleod’s Pharmaceuticals (India)
11.9.1 Mcleod’s Pharmaceuticals (India) Company Details
11.9.2 Mcleod’s Pharmaceuticals (India) Business Overview
11.9.3 Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Introduction
11.9.4 Mcleod’s Pharmaceuticals (India) Revenue in Brain Tumor Treatment Business (2019-2024)
11.9.5 Mcleod’s Pharmaceuticals (India) Recent Developments
11.10 Mankind Pharma (India)
11.10.1 Mankind Pharma (India) Company Details
11.10.2 Mankind Pharma (India) Business Overview
11.10.3 Mankind Pharma (India) Brain Tumor Treatment Introduction
11.10.4 Mankind Pharma (India) Revenue in Brain Tumor Treatment Business (2019-2024)
11.10.5 Mankind Pharma (India) Recent Developments
11.11 Dr. Reddy’s Laboratories (India)
11.11.1 Dr. Reddy’s Laboratories (India) Company Details
11.11.2 Dr. Reddy’s Laboratories (India) Business Overview
11.11.3 Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Introduction
11.11.4 Dr. Reddy’s Laboratories (India) Revenue in Brain Tumor Treatment Business (2019-2024)
11.11.5 Dr. Reddy’s Laboratories (India) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Brain Tumor Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Chemotherapy Table 3. Key Players of Targeted Therapy Table 4. Global Brain Tumor Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Brain Tumor Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Brain Tumor Treatment Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Brain Tumor Treatment Market Share by Region (2019-2024) Table 8. Global Brain Tumor Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Brain Tumor Treatment Market Share by Region (2025-2030) Table 10. Brain Tumor Treatment Market Trends Table 11. Brain Tumor Treatment Market Drivers Table 12. Brain Tumor Treatment Market Challenges Table 13. Brain Tumor Treatment Market Restraints Table 14. Global Brain Tumor Treatment Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Brain Tumor Treatment Revenue Share by Players (2019-2024) Table 16. Global Top Brain Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Treatment as of 2023) Table 17. Global Brain Tumor Treatment Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Brain Tumor Treatment Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Brain Tumor Treatment, Headquarters and Area Served Table 20. Global Key Players of Brain Tumor Treatment, Product and Application Table 21. Global Key Players of Brain Tumor Treatment, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Brain Tumor Treatment Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Brain Tumor Treatment Revenue Market Share by Type (2019-2024) Table 25. Global Brain Tumor Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Brain Tumor Treatment Revenue Market Share by Type (2025-2030) Table 27. Global Brain Tumor Treatment Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Brain Tumor Treatment Revenue Share by Application (2019-2024) Table 29. Global Brain Tumor Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Brain Tumor Treatment Revenue Share by Application (2025-2030) Table 31. North America Brain Tumor Treatment Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Brain Tumor Treatment Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Brain Tumor Treatment Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Brain Tumor Treatment Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Brain Tumor Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Brain Tumor Treatment Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Brain Tumor Treatment Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Brain Tumor Treatment Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Brain Tumor Treatment Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Brain Tumor Treatment Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Brain Tumor Treatment Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Brain Tumor Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Brain Tumor Treatment Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Brain Tumor Treatment Market Size by Country (2025-2030) & (US$ Million) Table 45. China Brain Tumor Treatment Market Size by Type (2019-2024) & (US$ Million) Table 46. China Brain Tumor Treatment Market Size by Type (2025-2030) & (US$ Million) Table 47. China Brain Tumor Treatment Market Size by Application (2019-2024) & (US$ Million) Table 48. China Brain Tumor Treatment Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Brain Tumor Treatment Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Brain Tumor Treatment Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Brain Tumor Treatment Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Brain Tumor Treatment Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Brain Tumor Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Brain Tumor Treatment Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Brain Tumor Treatment Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Brain Tumor Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Brain Tumor Treatment Market Size by Country (2025-2030) & (US$ Million) Table 63. Genetech (U.S.) Company Details Table 64. Genetech (U.S.) Business Overview Table 65. Genetech (U.S.) Brain Tumor Treatment Product Table 66. Genetech (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 67. Genetech (U.S.) Recent Developments Table 68. Bristol Mayers Squibb (U.S.) Company Details Table 69. Bristol Mayers Squibb (U.S.) Business Overview Table 70. Bristol Mayers Squibb (U.S.) Brain Tumor Treatment Product Table 71. Bristol Mayers Squibb (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 72. Bristol Mayers Squibb (U.S.) Recent Developments Table 73. Hoffman-La Roche (Switzerland) Company Details Table 74. Hoffman-La Roche (Switzerland) Business Overview Table 75. Hoffman-La Roche (Switzerland) Brain Tumor Treatment Product Table 76. Hoffman-La Roche (Switzerland) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 77. Hoffman-La Roche (Switzerland) Recent Developments Table 78. Astra Zeneca (India) Company Details Table 79. Astra Zeneca (India) Business Overview Table 80. Astra Zeneca (India) Brain Tumor Treatment Product Table 81. Astra Zeneca (India) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 82. Astra Zeneca (India) Recent Developments Table 83. Pfizer (U.S.) Company Details Table 84. Pfizer (U.S.) Business Overview Table 85. Pfizer (U.S.) Brain Tumor Treatment Product Table 86. Pfizer (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 87. Pfizer (U.S.) Recent Developments Table 88. Novartis (Switzerland) Company Details Table 89. Novartis (Switzerland) Business Overview Table 90. Novartis (Switzerland) Brain Tumor Treatment Product Table 91. Novartis (Switzerland) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 92. Novartis (Switzerland) Recent Developments Table 93. Antisenese Pharma (Mongolia) Company Details Table 94. Antisenese Pharma (Mongolia) Business Overview Table 95. Antisenese Pharma (Mongolia) Brain Tumor Treatment Product Table 96. Antisenese Pharma (Mongolia) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 97. Antisenese Pharma (Mongolia) Recent Developments Table 98. Merck (U.S.) Company Details Table 99. Merck (U.S.) Business Overview Table 100. Merck (U.S.) Brain Tumor Treatment Product Table 101. Merck (U.S.) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 102. Merck (U.S.) Recent Developments Table 103. Mcleod’s Pharmaceuticals (India) Company Details Table 104. Mcleod’s Pharmaceuticals (India) Business Overview Table 105. Mcleod’s Pharmaceuticals (India) Brain Tumor Treatment Product Table 106. Mcleod’s Pharmaceuticals (India) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 107. Mcleod’s Pharmaceuticals (India) Recent Developments Table 108. Mankind Pharma (India) Company Details Table 109. Mankind Pharma (India) Business Overview Table 110. Mankind Pharma (India) Brain Tumor Treatment Product Table 111. Mankind Pharma (India) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 112. Mankind Pharma (India) Recent Developments Table 113. Dr. Reddy’s Laboratories (India) Company Details Table 114. Dr. Reddy’s Laboratories (India) Business Overview Table 115. Dr. Reddy’s Laboratories (India) Brain Tumor Treatment Product Table 116. Dr. Reddy’s Laboratories (India) Revenue in Brain Tumor Treatment Business (2019-2024) & (US$ Million) Table 117. Dr. Reddy’s Laboratories (India) Recent Developments Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Global Brain Tumor Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Brain Tumor Treatment Market Share by Type: 2023 VS 2030 Figure 3. Chemotherapy Features Figure 4. Targeted Therapy Features Figure 5. Global Brain Tumor Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Brain Tumor Treatment Market Share by Application: 2023 VS 2030 Figure 7. Early Case Studies Figure 8. Mid-term Case Studies Figure 9. Later period Case Studies Figure 10. Brain Tumor Treatment Report Years Considered Figure 11. Global Brain Tumor Treatment Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 12. Global Brain Tumor Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 13. Global Brain Tumor Treatment Market Share by Region: 2023 VS 2030 Figure 14. Global Brain Tumor Treatment Market Share by Players in 2023 Figure 15. Global Top Brain Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Treatment as of 2023) Figure 16. The Top 10 and 5 Players Market Share by Brain Tumor Treatment Revenue in 2023 Figure 17. North America Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 18. North America Brain Tumor Treatment Market Share by Type (2019-2030) Figure 19. North America Brain Tumor Treatment Market Share by Application (2019-2030) Figure 20. North America Brain Tumor Treatment Market Share by Country (2019-2030) Figure 21. United States Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Canada Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Europe Brain Tumor Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 24. Europe Brain Tumor Treatment Market Share by Type (2019-2030) Figure 25. Europe Brain Tumor Treatment Market Share by Application (2019-2030) Figure 26. Europe Brain Tumor Treatment Market Share by Country (2019-2030) Figure 27. Germany Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. France Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. U.K. Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Italy Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Russia Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Nordic Countries Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. China Brain Tumor Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 34. China Brain Tumor Treatment Market Share by Type (2019-2030) Figure 35. China Brain Tumor Treatment Market Share by Application (2019-2030) Figure 36. Asia Brain Tumor Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 37. Asia Brain Tumor Treatment Market Share by Type (2019-2030) Figure 38. Asia Brain Tumor Treatment Market Share by Application (2019-2030) Figure 39. Asia Brain Tumor Treatment Market Share by Region (2019-2030) Figure 40. Japan Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. South Korea Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. China Taiwan Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. Southeast Asia Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. India Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Australia Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Middle East, Africa, and Latin America Brain Tumor Treatment Market Size YoY (2019-2030) & (US$ Million) Figure 47. Middle East, Africa, and Latin America Brain Tumor Treatment Market Share by Type (2019-2030) Figure 48. Middle East, Africa, and Latin America Brain Tumor Treatment Market Share by Application (2019-2030) Figure 49. Middle East, Africa, and Latin America Brain Tumor Treatment Market Share by Country (2019-2030) Figure 50. Brazil Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. Mexico Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Turkey Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Saudi Arabia Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Israel Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. GCC Countries Brain Tumor Treatment Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Genetech (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 57. Bristol Mayers Squibb (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 58. Hoffman-La Roche (Switzerland) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 59. Astra Zeneca (India) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 60. Pfizer (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 61. Novartis (Switzerland) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 62. Antisenese Pharma (Mongolia) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 63. Merck (U.S.) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 64. Mcleod’s Pharmaceuticals (India) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 65. Mankind Pharma (India) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 66. Dr. Reddy’s Laboratories (India) Revenue Growth Rate in Brain Tumor Treatment Business (2019-2024) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)